MINUTES
About Minutes
Back to latest

HealthFDA warns GLP-1 drugs may raise risk of rare vision-loss condition

The FDA says popular GLP-1 drugs, including Ozempic, Wegovy, Zepbound and Mounjaro, may increase the risk of a rare eye condition that can cause permanent vision loss. It will require manufacturers to add a warning to drug labels, though whether the medicines are linked to the condition remains uncertain.

GLP-1 drugsvision lossdrug safetyFDA

AArs Technica★★★☆☆2026-11-10 14:43Original

FDA warns GLP-1 drugs may raise risk of rare vision-loss condition
FDA warns GLP-1 drugs may raise risk of rare vision-loss conditionHealth